Autism spectrum disorder genetics: Diverse genes with diverse clinical outcomes

Harvard Review of Psychiatry

Volumn 22, Issue 2, 2014, Pages 65-75

  Talkowski, Michael E ^a   Minikel, Eric Vallabh ^a   Gusella, James F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Autism; Chromosome rearrangement; Common polymorphic variation; Copy number variation; Exome sequencing; Genetic architecture; Genetic association; Single nucleotide variation

Indexed keywords

NEUREXIN; NEUROLIGIN;

AUTISM; CHROMATIN; CHROMOSOME REARRANGEMENT; COPY NUMBER VARIATION; DEVELOPMENTAL DISORDER; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; EXOME; GENE EXPRESSION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HUMAN; PATHOGENESIS; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; GENETICS; GENOTYPE ENVIRONMENT INTERACTION;

CHILD DEVELOPMENT DISORDERS, PERVASIVE; GENE-ENVIRONMENT INTERACTION; HUMANS;

EID: 84902129480     PISSN: 10673229     EISSN: 14657309     Source Type: Journal    
DOI: 10.1097/HRP.0000000000000002     Document Type: Review

References (113)

1. Hertz-Picciotto I, Delwiche L. The rise in autism and the role of age at diagnosis. Epidemiol 2009;20:84-90.
2. Atladóttir HO, Parner ET, Schendel D, Dalsgaard S, Thomsen PH, Thorsen P. Time trends in reported diagnoses of childhood neuropsychiatric disorders: a Danish cohort study. Arch Pediatr Adolesc Med 2007;161:193-8. (Pubitemid 46232470)
3. Taylor B. Vaccines and the changing epidemiology of autism. Child Care Health Dev 2006;32:511-9. (Pubitemid 44210089)
4. Shattuck PT. Diagnostic substitution and changing autism prevalence. Pediatrics 2006;117:1438-9. (Pubitemid 46071542)
5. Fombonne E, Zakarian R, Bennett A, Meng L, McLean-Heywood D. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations. Pediatrics 2006;118:e139-50.
6. Elsabbagh M, Divan G, Koh Y-J, et al. Global prevalence of autism and other pervasive developmental disorders. Autism Res 2012;5:160-79.
7. Wing L, Yeates SR, Brierley LM, Gould J. The prevalence of early childhood autism: comparison of administrative and epidemiological studies. Psychol Med 1976;6:89-100.
8. Ritvo ER, Freeman BJ, Pingree C, et al. The UCLAUniversity of Utah epidemiologic survey of autism: prevalence. Am J Psychiatry 1989;146:194-9. (Pubitemid 19059566)
9. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators; Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008.MMWR Surveill Summ 2012;61:1-19.
10. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2000 Principal Investigators; Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, six sites, United States, 2000. MMWR Surveill Summ 2007;56:1-11.
11. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2006 Principal Investigators; Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders-Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ 2009;58:1-20.
12. Smalley SL, Asarnow RF, Spence MA. Autism and genetics. A decade of research. Arch Gen Psychiatry 1988;45:953-61.
13. Hoekstra RA, Bartels M, Verweij CJH, Boomsma DI. Heritability of autistic traits in the general population. Arch Pediatr Adolesc Med 2007;161:372-7. (Pubitemid 46556368)
14. Hallmayer J, Cleveland S, Torres A, et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 2011;68:1095-102.
15. Bailey A, Le Couteur A, Gottesman I, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995;25:63-77.
16. Yu TW, Chahrour MH, Coulter ME, et al. Using wholeexome sequencing to identify inherited causes of autism. Neuron 2013;77:259-73.
17. Lim ET, Raychaudhuri S, Sanders SJ, et al. Rare complete knockouts in humans: population distribution and significant role in autism spectrum disorders. Neuron 2013;77:235-42.
18. O'Roak BJ, Vives L, Fu W, et al. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 2012;338:1619-22.
19. O'Roak BJ, Vives L, Girirajan S, et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012;485:246-50.
20. O'Roak BJ, Deriziotis P, Lee C, et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet 2011;43:585-9.
21. Iossifov I, Ronemus M, Levy D, et al. De novo gene disruptions in children on the autistic spectrum. Neuron 2012;74:285-99.
22. Neale BM, Kou Y, Liu L, et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 2012;485:242-5.
23. Sanders SJ, Murtha MT, Gupta AR, et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 2012;485:237-41.
24. Michaelson JJ, Shi Y, Gujral M, et al. Whole-genome sequencing in autism identifies hot spots for de novo germline mutation. Cell 2012;151:1431-42.
25. Pinto D, Pagnamenta AT, Klei L, et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010;466:368-72.
26. Talkowski ME, Rosenfeld JA, Blumenthal I, et al. Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell 2012;149:525-37.
27. Sebat J, Lakshmi B, Malhotra D, et al. Strong association of de novo copy number mutations with autism. Science 2007;316:445-9. (Pubitemid 46651493)
28. Lionel AC, Vaags AK, Sato D, et al. Rare exonic deletions implicate the synaptic organizer Gephyrin (GPHN) in risk for autism, schizophrenia and seizures. Hum Mol Genet 2013;22:2055-66.
29. Handrigan GR, Chitayat D, Lionel AC, et al. Deletions in 16q24.2 are associated with autism spectrum disorder, intellectual disability and congenital renal malformation. J Med Genet 2013;50:163-73.
30. Beunders G, Voorhoeve E, Golzio C, et al. Exonic deletions in AUTS2 cause a syndromic form of intellectual disability and suggest a critical role for the C terminus. Am J Hum Genet 2013;92:210-20.
31. Girirajan S, Dennis MY, Baker C, et al. Refinement and discovery of new hotspots of copy-number variation associated with autism spectrum disorder. Am J Hum Genet 2013;92:221-37.
32. Marshall CR, Noor A, Vincent JB, et al. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 2008;82:477-88.
33. Weiss LA, Arking DE, Daly MJ, Chakravarti A. A genomewide linkage and association scan reveals novel loci for autism. Nature 2009;461:802-8.
34. Wang K, Zhang H, Ma D, et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 2009;459:528-33.
35. Anney R, Klei L, Pinto D, et al. A genome-wide scan for common alleles affecting risk for autism. Hum Mol Genet 2010;19:4072-82.
36. Klei L, Sanders SJ, Murtha MT, et al. Common genetic variants, acting additively, are a major source of risk for autism. Mol Autism 2012;3:9.
37. Girirajan S, Johnson RL, Tassone F, et al. Global increases in both common and rare copy number load associated with autism. Hum Mol Genet 2013;22:2870-80.
38. Cooper GM, Coe BP, Girirajan S, et al. A copy number variation morbidity map of developmental delay. Nat Genet 2011;43:838-46.
39. Williams SR, Mullegama SV, Rosenfeld JA, et al. Haploinsufficiency of MBD5 associated with a syndrome involving microcephaly, intellectual disabilities, severe speech impairment, and seizures. Eur J Hum Genet 2010;18: 436-41.
40. Talkowski ME, Mullegama SV, Rosenfeld JA, et al. Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder. Am J Hum Genet 2011;89:551-63.
41. Rosenfeld JA, Ballif BC, Torchia BS, et al. Copy number variations associated with autism spectrum disorders contribute to a spectrum of neurodevelopmental disorders. Genet Med 2010;12:694-702.
42. Ben-David E, Shifman S. Networks of neuronal genes affected by common and rare variants in autism spectrum disorders. PLoS Genet 2012;8:e1002556.
43. Ben-David E, Shifman S. Combined analysis of exome sequencing points toward a major role for transcription regulation during brain development in autism. Mol Psychiatry 2013;18:1054-6.
44. Cross-Disorder Group of the Psychiatric Genomics Consortium; Genetic Risk Outcome of Psychosis (GROUP) Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013;381:1371-9.
45. Miles JH. Autism spectrum disorders - a genetics review. Genet Med 2011;13:278-94.
46. Brown WT, Jenkins EC, Friedman E, et al. Autism is associated with the fragile-X syndrome. J Autism Dev Disord 1982;12:303-8. (Pubitemid 12035221)
47. Lam CW, Yeung WL, Ko CH, et al. Spectrum of mutations in the MECP2 gene in patients with infantile autism and Rett syndrome. J Med Genet 2000;37:E41.
48. Betancur C. Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res 2011;1380:42-77.
49. Butler MG, Dasouki MJ, Zhou X-P, et al. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet 2005;42: 318-21. (Pubitemid 40523954)
50. Steffenburg S, Gillberg CL, Steffenburg U, Kyllerman M. Autism in Angelman syndrome: a population-based study. Pediatr Neurol 1996;14:131-6. (Pubitemid 26104417)
51. Gillberg C, Forsell C. Childhood psychosis and neurofibromatosis - more than a coincidence? J Autism Dev Disord 1984;14:1-8.
52. Bolton PF, Griffiths PD. Association of tuberous sclerosis of temporal lobes with autism and atypical autism. Lancet 1997;349:392-5. (Pubitemid 27077668)
53. Jamain S, Quach H, Betancur C, et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 2003;34:27-9. (Pubitemid 36548785)
54. Durand CM, Betancur C, Boeckers TM, et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet 2007;39:25-7. (Pubitemid 46026497)
55. Strauss KA, Puffenberger EG, Huentelman MJ, et al. Recessive symptomatic focal epilepsy and mutant contactinassociated protein-like 2. N Engl J Med 2006;354:1370-7.
56. Hindorff LA, Sethupathy P, Junkins HA, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 2009;106:9362-7.
57. Purcell SM, Wray NR, Stone JL, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009;460:748-52.
58. Genome-wide association study identifies five new schizophrenia loci. Nat Genet 2011;43:969-76.
59. Devlin B, Melhem N, Roeder K. Do common variants play a role in risk for autism? Evidence and theoretical musings. Brain Res 2011;1380:78-84.
60. Fischbach GD, Lord C. The Simons Simplex Collection: a resource for identification of autism genetic risk factors. Neuron 2010;68:192-5.
61. Lajonchere CM. Changing the landscape of autism research: the autism genetic resource exchange. Neuron 2010;68:187-91.
62. MacArthur DG, Balasubramanian S, Frankish A, et al. A systematic survey of loss-of-function variants in human protein-coding genes. Science 2012;335:823-8.
63. Nava C, Lamari F, Héron D, et al. Analysis of the chromosome X exome in patients with autism spectrum disorders identified novel candidate genes, including TMLHE. Transl Psychiatry 2012;2:e179.
64. Puffenberger EG, Jinks RN, Wang H, et al. A homozygous missense mutation in HERC2 associated with global developmental delay and autism spectrum disorder. Hum Mutat 2012;33:1639-46.
65. Chahrour MH, Yu TW, Lim ET, et al. Whole-exome sequencing and homozygosity analysis implicate depolarizationregulated neuronal genes in autism. PLoS Genet 2012;8: e1002635.
66. Bi C, Wu J, Jiang T, et al. Mutations of ANK3 identified by exome sequencing are associated with autism susceptibility. Hum Mutat 2012;33:1635-8.
67. Korbel JO, Urban AE, Affourtit JP, et al. Paired-end mapping reveals extensive structural variation in the human genome. Science 2007;318:420-6. (Pubitemid 47614521)
68. Talkowski ME, Ernst C, Heilbut A, et al. Next-generation sequencing strategies enable routine detection of balanced chromosome rearrangements for clinical diagnostics and genetic research. Am J Hum Genet 2011;88:469-81.
69. Manning M, Hudgins L. Use of array-based technology in the practice of medical genetics. Genet Med 2007; 9:650-3. (Pubitemid 47415275)
70. Xu J, Zwaigenbaum L, Szatmari P, Scherer SW. Molecular cytogenetics of autism. Curr Genomics 2004;5:347-64. (Pubitemid 38618061)
71. Iafrate AJ, Feuk L, Rivera MN, et al. Detection of large-scale variation in the human genome. Nat Genet 2004;36:949-51. (Pubitemid 39167488)
72. Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature 2006;444: 444-54. (Pubitemid 44809057)
73. Sebat J, Lakshmi B, Troge J, et al. Large-scale copy number polymorphism in the human genome. Science 2004;305:525-8. (Pubitemid 38971344)
74. Cook EH Jr, Scherer SW. Copy-number variations associated with neuropsychiatric conditions. Nature 2008;455:919-23.
75. Sanders SJ, Ercan-Sencicek AG, Hus V, et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 2011;70:863-85.
76. Weiss LA, Shen Y, Korn JM, et al. Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 2008;358:667-75. (Pubitemid 351240746)
77. Van Bon BWM, Mefford HC, Menten B, et al. Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome. J Med Genet 2009;46:511-23.
78. Vorstman JAS, Morcus MEJ, Duijff SN, et al. The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms. J Am Acad Child Adolesc Psychiatry 2006;45:1104-13. (Pubitemid 44343066)
79. Smalley SL. Autism and tuberous sclerosis. J Autism Dev Disord 1998;28:407-14. (Pubitemid 29101856)
80. Mefford HC, Sharp AJ, Baker C, et al. Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N Engl J Med 2008;359:1685-99.
81. De Ravel TJ, Balikova I, Thiry P, Vermeesch JR, Frijns J-P. Another patient with a de novo deletion further delineates the 2q33.1 microdeletion syndrome. Eur J Med Genet 2009;52:120-2.
82. Rosenfeld JA, Ballif BC, Lucas A, et al. Small deletions of SATB2 cause some of the clinical features of the 2q33.1 microdeletion syndrome. PloS One 2009;4:e6568.
83. Balasubramanian M, Smith K, Basel-Vanagaite L, et al. Case series: 2q33.1 microdeletion syndrome - further delineation of the phenotype. J Med Genet 2011;48:290-8.
84. Hodge JC, Mitchell E, Pillalamarri V, et al. Disruption of MBD5 contributes to a spectrum of psychopathology and neurodevelopmental abnormalities. Mol Psychiatry 2013 Apr 16 [Epub ahead of print].
85. Kleefstra T, Kramer JM, Neveling K, et al. Disruption of an EHMT1-associated chromatin-modification module causes intellectual disability. Am J Hum Genet 2012;91:73-82.
86. Golzio C, Willer J, Talkowski ME, et al. KCTD13 is a major driver of mirrored neuroanatomical phenotypes of the 16p11.2 copy number variant. Nature 2012;485:363-7.
87. McCarthy SE, Makarov V, Kirov G, et al. Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet 2009;41:1223-7.
88. Jacquemont S, Reymond A, Zufferey F, et al. Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus. Nature 2011;478: 97-102.
89. Walters RG, Jacquemont S, Valsesia A, et al. A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Nature 2010;463:671-5.
90. Kumar RA, Kara Mohamed S, Sudi J, et al. Recurrent 16p11.2 microdeletions in autism. Hum Mol Genet 2008; 17:628-38. (Pubitemid 351201774)
91. Sultana R, Yu C-E, Yu J, et al. Identification of a novel gene on chromosome 7q11.2 interrupted by a translocation breakpoint in a pair of autistic twins. Genomics 2002; 80:129-34. (Pubitemid 36197952)
92. Kim H-G, Kishikawa S, Higgins AW, et al. Disruption of neurexin 1 associated with autism spectrum disorder. Am J Hum Genet 2008;82:199-207. (Pubitemid 351735950)
93. Chen W, Kalscheuer V, Tzschach A, et al. Mapping translocation breakpoints by next-generation sequencing. Genome Res 2008;18:1143-9. (Pubitemid 351931165)
94. Chen W, Ullmann R, Langnick C, et al. Breakpoint analysis of balanced chromosome rearrangements by nextgeneration paired-end sequencing. Eur J Hum Genet 2010; 18:539-43.
95. Chiang C, Jacobsen JC, Ernst C, et al. Complex reorganization and predominant non-homologous repair following chromosomal breakage in karyotypically balanced germline rearrangements and transgenic integration. Nat Genet 2012; 44:390-397, S1.
96. Stephens PJ, Greenman CD, Fu B, et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 2011;144:27-40.
97. Sato D, Lionel AC, Leblond CS, et al. SHANK1 deletions in males with autism spectrum disorder. Am J Hum Genet 2012;90:879-87.
98. Leblond CS, Heinrich J, Delorme R, et al. Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. PLoS Genet 2012; 8:e1002521.
99. Berkel S, Tang W, Trevin?o M, et al. Inherited and de novo SHANK2 variants associated with autism spectrum disorder impair neuronal morphogenesis and physiology. Hum Mol Genet 2012;21:344-57.
100. Moessner R, Marshall CR, Sutcliffe JS, et al. Contribution of SHANK3 mutations to autism spectrum disorder. Am J Hum Genet 2007;81:1289-97. (Pubitemid 350211458)
101. Gauthier J, Spiegelman D, Piton A, et al. Novel de novo SHANK3 mutation in autistic patients. Am J Med Genet B Neuropsychiatr Genet 2009;150B:421-4.
102. Gauthier J, Siddiqui TJ, Huashan P, et al. Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. Hum Genet 2011;130: 563-73.
103. Vaags AK, Lionel AC, Sato D, et al. Rare deletions at the neurexin 3 locus in autism spectrum disorder. Am J Hum Genet 2012;90:133-41.
104. Glessner JT, Wang K, Cai G, et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 2009;459:569-73.
105. Ernst C, Marshall CR, Shen Y, et al. Highly penetrant alterations of a critical region including BDNF in human psychopathology and obesity. Arch Gen Psychiatry 2012; 69:1238-46.
106. Auerbach BD, Osterweil EK, Bear MF. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 2011;480:63-8.
107. Ebert DH, Greenberg ME. Activity-dependent neuronal signalling and autism spectrum disorder. Nature 2013;493:327-37.
108. Voineagu I, Wang X, Johnston P, et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 2011;474:380-4.
109. Rosenfeld JA, Leppig K, Ballif BC, et al. Genotypephenotype analysis of TCF4 mutations causing Pitt-Hopkins syndrome shows increased seizure activity with missense mutations. Genet Med 2009;11:797-805.
110. Pitt D, Hopkins I. A syndrome of mental retardation, wide mouth and intermittent overbreathing. Aust Paediatr J 1978;14:182-4. (Pubitemid 9054849)
111. Ripke S, Wray NR, Lewis CM, et al. A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry 2013;18:497-511.
112. Chung BHY, Stavropoulos J, Marshall CR, Weksberg R, Scherer SW, Yoon G. 2q23 de novo microdeletion involving the MBD5 gene in a patient with developmental delay, postnatal microcephaly and distinct facial features. Am J Med Genet A 2011;155A:424-9.
113. Mullegama SV, Rosenfeld JA, Orellana C, et al. Reciprocal deletion and duplication at 2q23.1 indicates a role for MBD5 in autism spectrum disorder. Eur J Hum Genet 2013 May 1 [Epub ahead of print].